Synthetic Design for Combinatorial Chemistry
J. Am. Chem. Soc., Vol. 119, No. 26, 1997 6165
bicycle 6 as X-ray quality crystals (153 mg, 47% overall yield): mp
138-140 °C; IR 1677 cm-1; 1H NMR δ 7.20 (d, 2, J ) 8.7), 6.86 (d,
2, J ) 8.7), 3.98 (m, 1), 3.92 (d, 1, J ) 7.8), 3.80 (s, 3), 3.54 (dd, 1,
J ) 8.2, 10.0), 3.46 (dd, 1, J ) 6.3, 9.8), 3.08 (dd, 1, J ) 2.2, 10.0),
2.95 (m, 1), 2.43 (s, 3), 2.14 (m, 1), 1.91 (ddd, 1, J ) 2.5, 6.3, 13.0),
1.81-1.70 (m, 5), 1.47-1.32 (m, 4), 1.12 (m, 1); 13C NMR δ 171.2,
158.9, 133.6, 128.5, 113.8, 68.1, 66.6, 55.3, 50.5, 48.8, 44.2, 35.1, 32.5,
30.8, 29.9, 25.5, 25.4; MS (EI) 312.8 (100, M+); Anal. Calcd for
C20H28N2O2: C, 73.14; H, 8.59; N, 8.53. Found: C, 73.27; H, 8.50;
N, 8.55.
N-Allyl-N-phenylglyoxamide (21). To a solution of 190 mg (0.5
mmol) of diol 20 in 1 mL of diethyl ether and 0.5 mL of THF stirred
at 0 °C was added 114 mg (0.5 mmol) of periodic acid dihydrate in
two portions over 30 min. Stirring at 0 °C was continued for an
additional 45 min after which time a white solid had precipitated. The
supernatant was decanted, dried over 4Å molecular sieves, and
concentrated in vacuo to afford 164 mg (80%) of the glyoxamide 21
and its hydrate as a pale yellow oil: 1H NMR δ 4.40 (m, 2), 5.12-
5.24 (m, 2), 5.81-5.91 (m, 1), 7.15-7.45 (m, 5), 9.36 (s, 1). This
material was not purified but carried on directly into subsequent
reactions.
[3aR*-(3aσ,4r,5σ,9aR*)]-2,4,5-Triphenylhexahydro-2H,7H-pyr-
rolo[3,4-d]pyrrolizin-1-one (7). A solution of proline N-phenyl-N-
(E)-3-phenyl-2-propenyl amide (195 mg, 0.64 mmol), benzaldehyde
(135 mg, 1.30 mmol), and Et3N (89 µL, 0.64 mmol) in toluene (5 mL)
was reacted according to the general cyclization procedure. Chroma-
tography (4:1 hexanes/EtOAc) gave tricycle 7 as a white solid (160
mg, 63%). A small sample was recrystallized from EtOAc/hexanes to
provide an X-ray quality analytical sample: mp 203-204 °C; TLC Rf
[7aR*-(7ar,10ar,11aâ)]-5,6,7a,9,10,10a,11,11a-Octahydro-9-phenyl-
8H-pyrrolo[3′,4′:4,5]pyrrolo[2,1-a]isoquinolin-8-one (22). A solution
of 133 mg (1 mmol) of 1,2,3,4-tetrahydroisoquinoline, 101 mg (1 mmol)
of Et3N, and the crude preparation of glyoxamide 21 and its hydrate
(0.8 mmol) in 2 mL of toluene was stirred under nitrogen at 110 °C
for 20 h. After cooling, the solution was diluted with 30 mL of CH2-
Cl2 and washed with 15 mL of saturated NaHCO3. The aqueous wash
was extracted with two 20-mL portions of CH2Cl2, and the combined
organic extracts were dried (MgSO4) and concentrated in vacuo. The
residue was purified by chromatography (EtOAc/hexanes, 2:1) to afford
174 mg (72%) of tetracycle 22 as a white solid after evaporation of
the solvent: mp 165-166 °C; 1H NMR δ 2.24-2.38 (m, 2), 2.87 (dt,
1, J ) 15.6, 4.4), 3.02-3.08 (m, 2), 3.24-3.30 (m, 1), 3.44 (dt, 1, J )
17.2, 4.9), 3.66 (dd, 1, J ) 10.1, 2.3), 3.98 (d, 1, J ) 8.5), 4.10 (dd,
1, J ) 10.1, 8.1), 4.26 (t, 1, J ) 7.0), 7.04-7.07 (m, 1), 7.11-7.19
(m, 4), 7.36-7.40 (m, 2), 7.67-7.69 (m, 2); 13C NMR δ 26.9, 32.5,
39.8, 45.7, 53.2, 61.2, 68.2, 120.1, 124.9, 126.0, 126.1, 126.4, 128.86,
128.88, 134.4, 137.1, 139.1, 172.2. Anal. Calcd for C20H20N2O: C,
78.92; H, 6.62; N, 9.20. Found: C, 78.66; H, 6.72; N, 9.12.
1
) 0.20 (4:1 hexanes/EtOAc); IR 1700, 1494 cm-1; H NMR δ 7.72
(d, 2, J ) 8.0), 7.34 (dd, 2, J ) 7.8, 7.8), 7.29-6.99 (m, 7), 6.92 (d,
2, J ) 7.1), 6.88 (d, 2, J ) 7.2), 4.76 (d, 1, J ) 7.5), 4.13-4.08 (m,
2), 3.47 (d, 1, J ) 10.0), 3.29 (dd, 1, J ) 6.1, 11.9), 3.10 (m, 1), 2.88
(m, 1), 2.52 (m, 1), 2.24 (m, 1), 2.11-2.03 (m, 2); 13C NMR δ 177.9,
139.7, 137.5, 137.0, 129.6, 128.7, 128.1, 127.9, 127.8, 127.0, 126.5,
124.4, 119.5, 79.7, 72.3, 58.1, 47.9, 47.6, 41.9, 34.1, 28.3; MS (FAB)
m/z 395 (100, MH+); Anal. Calcd for C27H26N2O: C, 82.20; H, 6.64;
N, 7.10. Found: C, 81.83; H, 6.71; N, 6.95.
N,N′-Diallyl-N,N′-diphenyltartramide (20). To a solution of 3.00
g (15.8 mmol) of tartaric acid acetonide74 and 4.21 g (31.6 mmol) of
N-allylaniline in 160 mL of THF stirred at 0 °C was added successively
0.434 g (31.6 mmol) of 1-hydroxybenzotriazole and 6.52 g (31.6 mmol)
of dicyclohexylcarbodiimide. The mixture was stirred at room tem-
perature for 20 h, filtered and concentrated in vacuo. The crude yellow
oil was purified by column chromatography over 150 g of silica gel
(EtOAc/hexanes, 1:5) to afford 5.71 g (86%) of the diamide as a white
solid after evaporation of the solvent: mp 73-74 °C; 1H NMR δ 1.20
(s, 6), 4.19 (dd, 2, J ) 14.6, 6.2), 4.29 (dd, 2, J ) 14.6, 6.0), 4.70 (s,
2), 5.03-5.11 (m, 4), 5.75-5.85 (m, 2), 7.18-7.20 (m, 4), 7.33-7.40
(m, 6); 13C NMR δ 26.2, 52.9, 75.9, 112.1, 118.2, 128.1, 128.3, 129.3,
132.4, 141.0, 167.6. Anal. Calcd for C25H28N2O4: C, 71.41; H, 6.71;
N, 6.66. Found: C, 71.64; H, 6.81; N, 6.68.
N-(3-Butenyl)-N-phenyl[2R*-(2r,3ar,6ar)]-Hexahydro-1-methyl-
6-oxo-5-phenyl-1H-pyrrolo[3,4-b]pyrrole-2-carboxamide (Scheme
11). To a solution of 102 mg (0.25 mmol) of the di(N-homoallyl-N-
phenyl)tartramide in 0.5 mL of THF and 1 mL of diethyl ether stirred
in an ice bath was added 57 mg (0.25 mmol) of periodic acid dihydrate
in two portions over 30 min. Stirring was continued for an additional
45 min, at which time a white solid had deposited on the bottom of
the flask. The clear supernatant was decanted, dried (4Å molecular
sieves), concentrated in vacuo, diluted with 1 mL of toluene, and added
dropwise to a solution of 96 mg (0.47 mmol) of sarcosine N-allylanilide
and 66 µL (0.47 mmol) of Et3N in 1 mL of toluene. The mixture was
heated at 110 °C for 5 h, diluted with 40 mL of CH2Cl2, and washed
with 20 mL of saturated NaHCO3. The NaHCO3 wash was extracted
with two 20-mL portions of CH2Cl2. The combined organic extracts
were dried (MgSO4) and concentrated in vacuo. The residue was
purified by column chromatography over 30 g of silica gel (hexanes/
EtOAc, 1:1 then 1:2) to afford 128 mg (72%) of the 5,5-bicyclic adduct
as a pale yellow oil: 1H NMR δ 1.73-1.80 (m, 1), 2.23-2.33 (m, 3),
2.69 (s, 3), 3.34-3.39 (m, 2), 3.71-3.75 (m, 1), 3.77-3.85 (m, 2),
3.92 (m, 1, J ) 8.9), 3.98 (dd, 1, J ) 10.3, 8.7), 5.04-5.11 (m, 2),
5.73-5.83 (m, 1), 7.09-7.13 (m, 3), 7.29-7.36 (m, 3), 7.39-7.43 (m,
2), 7.53-7.55 (m, 2); 13C NMR δ 32.2, 33.7, 36.9, 37.7, 48.3, 52.7,
64.2, 69.5, 116.8, 120.2, 124.7, 128.2, 128.4, 128.7, 129.9, 135.2, 139.3,
141.8, 172.1, 176.0. Anal. Calcd for C24H27N3O2: C, 74.01; H, 6.99;
N, 10.79. Found: C, 74.21; H, 7.10; N, 10.65. The same compound
was isolated in 62% yield on combination of sarcosine N-homoallyl-
anilide and N-allylglyoxanilide.
To a solution of 5.50 g (12.6 mmol) of the tartramide acetonide in
60 mL of THF was added 60 mL of 1 M HCl. The mixture was heated
at reflux for 24 h, allowed to cool to room temperature, neutralized by
addition of saturated NaHCO3, and extracted with four 80-mL portions
of EtOAc. The combined organic extracts were dried (MgSO4) and
concentrated in vacuo. The crude brown solid was recrystallized from
EtOAc/hexanes to afford 3.37 g (71%) of tartramide 20 as a white
1
solid after evaporation of the solvent: mp 126-127 °C; H NMR δ
3.26 (br s, 2), 3.65 (s, 2), 4.10 (dd, 2, J ) 14.7, 6.0), 4.35 (dd, 2, J )
14.7, 5.6), 5.03-5.09 (m, 4), 5.73-5.80 (m, 2), 6.90 (br s, 4), 7.15-
7.27 (m, 6); 13C NMR δ 53.8, 69.7, 118.4, 128.0, 128.4, 129.7, 132.1,
139.8, 169.7. Anal. Calcd for C22H24N2O4: C, 69.46; H, 6.36; N,
7.36. Found: C, 69.47; H, 6.47; N, 7.36.
General Procedure for Formation of Glyoxamides and Conden-
sation with Amine Components. A solution of the symmetrical
tartramide precursor (0.25-0.5 mmol) in 1 mL of diethyl ether and
0.5 mL of THF is stirred at 0 °C and 1 equiv of periodic acid dihydrate
is added in two portions over 30 min. Stirring at 0 °C is continued for
an additional 45 min during which time a white solid precipitates. The
supernatant is decanted, dried over 4Å molecular sieves, and concen-
trated in vacuo to afford the glyoxamide and its hydrate as a pale yellow
oil. This material is not purified but carried on directly into subsequent
reactions.
[3aR*-(3ar,6ar)]-Hexahydro-1-methyl-5-phenyl-1H-pyrrolo[3,4-
b]pyrrol-6-one (28, Table 2, Entry 5). A mixture of 45 mg (0.5 mmol)
of sarcosine and 272 µL (1.1 mmol) of bis-trimethylsilylacetamide in
0.5 mL of acetonitrile was stirred at room temperature for 1 h and at
40 °C for 30 min and then combined with a solution of glyoxamide 2
derived from 90 mg (0.25 mmol) of the tartramide precursor 2 in 1
mL of toluene. The resulting mixture was heated at reflux for 18 h
and worked up as described for the general procedure to give 40 mg
(40%) of the bicyclic product as a pale yellow oil: 1H NMR δ 1.74-
1.83 (m, 1), 2.19-2.26 (m, 1), 2.49 (dt, 1, J ) 9.4, 6.4), 2.65 (s, 3),
2.93-3.02 (m, 1), 3.06-3.10 (m, 1), 3.19 (d, 1, J ) 9.1), 3.59 (dd, 1,
J ) 9.9, 3.9), 4.00 (dd, 1, J ) 9.9, 8.6), 7.11-7.15 (m, 1), 7.32-7.37
(m, 2), 7.61-7.64 (m, 2); 13C NMR δ 32.5, 34.5, 41.3, 53.8, 57.3,
85.0, 120.2, 124.7, 128.8, 139.3, 172.8; HRMS calcd for C13H17N2O
(MH+) m/z 217.1341, found m/z 217.1346.
A solution of the crude glyoxamide and 1-1.25 equiv of the amine
in toluene with 1-2 equiv of Et3N is heated at reflux for 18 h, cooled,
diluted with CH2Cl2, and washed with saturated NaHCO3. The aqueous
wash is back-extracted with CH2Cl2, and the combined organic extracts
are dried (MgSO4) and concentrated on a rotary evaporator. The residue
is purified by chromatography (EtOAc/hexanes) to afford the cycload-
duct. The following compounds were prepared in this fashion, with
the amount and yield of the purified product indicated.